Valuation: Illumina, Inc.

Market Cap 29.48B 25.9B 24.18B 22.19B 41.53B 2,823B 42.56B 287B 112B 1,397B 111B 108B 4,830B P/E 2026 *
41.6x
P/E 2027 * 34.2x
Enterprise Value 29.97B 26.33B 24.58B 22.56B 42.23B 2,870B 43.27B 291B 114B 1,420B 113B 110B 4,910B EV / Sales 2026 *
6.56x
EV / Sales 2027 * 6.06x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day+0.95%
1 week+2.07%
Current month+10.80%
1 month+7.58%
3 months+61.85%
6 months+30.15%
Current year+48.54%
1 week 187.67
Extreme 187.67
198
1 month 175.6
Extreme 175.6
199.14
Current year 112.65
Extreme 112.65
199.14
1 year 88
Extreme 88
199.14
3 years 68.7
Extreme 68.7
199.14
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

167 0.0001%
30/06/26
Corvex Management LP
OtherCompany 0 0%
30/06/26 Free

Director

142 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.95%+2.07%+79.21%+1.24% 29.48B
+0.01%+9.50%+19.56%+2.60% 214B
-1.29%+9.69%-5.01%-24.45% 138B
-2.40%+3.64%-28.94%+8.14% 125B
-0.04%+7.14%-56.76%-10.93% 68.43B
+2.49%+1.65%+6.57%+2.41% 49.38B
-0.45%+9.73%-24.55%-29.31% 47.55B
-0.17%+5.13%+17.07%+11.31% 39.63B
-1.15%+2.34%+25.16%+32.79% 37.26B
+2.55%+11.08%-22.83%-3.98% 30.91B
Average -0.00%+5.83%+0.95%-1.02% 77.97B
Weighted average by Cap. -0.45%+7.00%-2.05%-2.88%

Financials

2026 *2027 *
Net sales 4.57B 4.02B 3.75B 3.44B 6.44B 438B 6.6B 44.45B 17.38B 217B 17.16B 16.79B 749B 4.83B 4.24B 3.96B 3.64B 6.81B 463B 6.97B 46.99B 18.37B 229B 18.14B 17.74B 792B
Net income 724M 636M 593M 545M 1.02B 69.31B 1.04B 7.04B 2.75B 34.3B 2.72B 2.66B 119B 871M 766M 715M 656M 1.23B 83.47B 1.26B 8.48B 3.31B 41.31B 3.27B 3.2B 143B
Net Debt 492M 432M 403M 370M 693M 47.08B 710M 4.78B 1.87B 23.3B 1.85B 1.81B 80.54B -222M -195M -182M -167M -312M -21.22B -320M -2.15B -843M -10.5B -832M -814M -36.3B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
29/07/26 US$194.82 +0.95% 1,694,087
28/07/26 US$192.98 +1.85% 2,112,806
27/07/26 US$189.47 -2.38% 1,738,894
24/07/26 US$194.09 -1.41% 1,301,036
23/07/26 US$196.86 +3.14% 1,220,931
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
194.82USD
Average target price
172.53USD
Spread / Average Target
-11.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock